AlphaStocks
5.5
Consider Buy

Edwards Lifesciences Corp (EW)

As of Sep 20, 2026, Edwards Lifesciences Corp (EW) scores 5.5/10 on AlphaStocks' five-model composite, #78 of 168 Health Care stocks. At $88, EW trades 45% above its model fair value of $61.

Health Care / Health Care Equipment

S&P 500

$88.26

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#78out of 168 in Health Care

Is Edwards Lifesciences Corp a Good Investment in 2026?

Edwards Lifesciences Corp (EW) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Edwards Lifesciences Corp as Attractive (6/9). The Lynch model is the least favorable, rating it Neutral. Edwards Lifesciences Corp currently trades 45% above its estimated fair value of $61. Edwards Lifesciences Corp ranks #78 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E48.2ROE8.8Market Cap51B

Estimated Fair Value

$61.0645% above

Trading above estimated fair value. P/e of 48x implies high growth expectations. eps growth of -74% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

PEG 4.1 · Stalwart

Greenblatt

Attractive

Earnings yield 7.1% · ROC 55%

Frequently Asked Questions

Is Edwards Lifesciences Corp (EW) a good investment?
As of Sep 20, 2026, Edwards Lifesciences Corp (EW) scores 5.5/10 on AlphaStocks' five-model composite, #78 of 168 Health Care stocks. At $88, EW trades 45% above its model fair value of $61. That is a middle-of-the-pack score with no strong signal either way.
What is Edwards Lifesciences Corp's Piotroski F-Score?
Edwards Lifesciences Corp's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is EW overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $61, EW appears overvalued. The stock currently trades 45% above its estimated fair value. Trading above estimated fair value. P/e of 48x implies high growth expectations. eps growth of -74% may not justify the premium.
How does EW compare to other Health Care stocks?
Edwards Lifesciences Corp ranks #78 out of 168 stocks in the Health Care sector, placing it in the top 46% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about EW?
AlphaStocks evaluates EW using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.5/10.

Similar Stocks

INSPUFPTBDX

Compare EW with

EW vs INSPEW vs UFPTBDX vs EWEW vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer